AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LEVOFLOXACIN 750.000 Mg ;

9 registrations across 1 African market— 9 active

Markets with LEVOFLOXACIN 750.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
DEBACOLEV 750 mg
Film Coated Tablets
🇪🇬EgyptD.B.K FOR PHARMACEUTICAL INDUSTRIESactive
MEGABIO 750mg
Film Coated Tablets
🇪🇬EgyptHochster pharmaceutical industriesactive
Uniloxam 750 mg
Film Coated Tablets
🇪🇬Egyptuniversal pharmaceutical industries (unipharma)active
LEVANIC 750mg
Film Coated Tablets
🇪🇬EgyptMedical Union Pharmaceuticals - MUPactive
MEGABIO 750mg
Film Coated Tablets
🇪🇬EgyptHochster pharmaceutical industriesactive
Levotavin 750 mg
Film Coated Tablets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Alfaspect 750 mg
Film Coated Tablets
🇪🇬EgyptInnogen Pharma For Medical Productsactive
LEVANIC 750mg
Film Coated Tablets
🇪🇬EgyptMedical Union Pharmaceuticals - MUPactive
ALFACEF 750mg
Film Coated Tablets
🇪🇬EgyptSpimaco Misr for pharmaceutical industriesactive

LEVOFLOXACIN 750.000 Mg ; in Africa — Regulatory Overview

LEVOFLOXACIN 750.000 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.